Persistence of a methicillin-resistant Staphylococcus aureus clone in a drug-use network.

cited because of space limitations but were referred to in a review [11] that was cited. These data reveal important insights into the mechanisms underlying the human immune response to Cryptosporidium species. White et al. [1] also point out that nitazoxanide recently received approval from the US Food and Drug Administration (after the submission of our review) for the treatment of cryptosporidiosis and giardiasis in children [12].